Papers - TOMITA Hirofumi
-
Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine.
Tanaka M, Osanai T, Murakami R, Sasaki S, Tomita H, Maeda N, Satoh K, Magota K, Okumura K
Journal of hypertension 24 ( 3 ) 489 - 97 2006.3
-
Intracellular signaling for vasoconstrictor coupling factor 6: novel function of beta-subunit of ATP synthase as receptor.
Tomohiro Osanai, Koji Magota, Makoto Tanaka, Michiko Shimada, Reiichi Murakami, Satoko Sasaki, Hirofumi Tomita, Naotaka Maeda, Ken Okumura
Hypertension 46 ( 5 ) 1140 - 1146 2005.11
-
Intracellular signaling for vasoconstrictor coupling factor 6: novel function of beta-subunit of ATP synthase as receptor.
Osanai T, Magota K, Tanaka M, Shimada M, Murakami R, Sasaki S, Tomita H, Maeda N, Okumura K
Hypertension (Dallas, Tex. : 1979) 46 ( 5 ) 1140 - 6 2005.11
-
Roxithromycin is an inhibitor of human coronary artery smooth muscle cells proliferation: a potential ability to prevent coronary heart disease.
Hirofumi Tomita, Tomohiro Osanai, Tsutomu Toki, Naotaka Maeda, Reiichi Murakami, Zhaoning Chen, Hideaki Yamabe, Hiroshi Osawa, Minoru Yasujima, Ken Okumura
Atherosclerosis 182 ( 1 ) 87 - 95 2005.9
-
Roxithromycin is an inhibitor of human coronary artery smooth muscle cells proliferation: a potential ability to prevent coronary heart disease.
Tomita H, Osanai T, Toki T, Maeda N, Murakami R, Chen Z, Yamabe H, Osawa H, Yasujima M, Okumura K
Atherosclerosis 182 ( 1 ) 87 - 95 2005.9
-
Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells.
Hirofumi Tomita, Tomohiro Osanai, Tsutomu Toki, Satoko Sasaki, Naotaka Maeda, Reiichi Murakami, Koji Magota, Minoru Yasujima, Ken Okumura
Cardiovascular research 67 ( 1 ) 134 - 141 2005.7
-
Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells.
Tomita H, Osanai T, Toki T, Sasaki S, Maeda N, Murakami R, Magota K, Yasujima M, Okumura K
Cardiovascular research 67 ( 1 ) 134 - 41 2005.7
-
Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6.
Satoko Sasaki, Tomohiro Osanai, Hirofumi Tomita, Toshiro Matsunaga, Koji Magota, Ken Okumura
Cardiovascular research 62 ( 3 ) 578 - 586 2004.6
-
Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6.
Sasaki S, Osanai T, Tomita H, Matsunaga T, Magota K, Okumura K
Cardiovascular research 62 ( 3 ) 578 - 86 2004.6
-
Circulating coupling factor 6 in human hypertension: role of reactive oxygen species.
Tomohiro Osanai, Satoko Sasaki, Takaatsu Kamada, Naoto Fujiwara, Takao Nakano, Hirofumi Tomita, Toshiro Matsunaga, Koji Magota, Ken Okumura
Journal of hypertension 21 ( 12 ) 2323 - 2328 2003.12
-
Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease.
Tomohiro Osanai, Masayuki Nakamura, Satoko Sasaki, Hirofumi Tomita, Masayuki Saitoh, Hiroshi Osawa, Hideaki Yamabe, Shuichi Murakami, Koji Magota, Ken Okumura
Kidney international 64 ( 6 ) 2291 - 2297 2003.12
-
Circulating coupling factor 6 in human hypertension: role of reactive oxygen species.
Osanai T, Sasaki S, Kamada T, Fujiwara N, Nakano T, Tomita H, Matsunaga T, Magota K, Okumura K
Journal of hypertension 21 ( 12 ) 2323 - 8 2003.12
-
Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease.
Osanai T, Nakamura M, Sasaki S, Tomita H, Saitoh M, Osawa H, Yamabe H, Murakami S, Magota K, Okumura K
Kidney international 64 ( 6 ) 2291 - 7 2003.12
-
Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells.
Tomohiro Osanai, Masayuki Saitoh, Satoko Sasaki, Hirofumi Tomita, Toshiro Matsunaga, Ken Okumura
Hypertension 42 ( 5 ) 985 - 990 2003.11
-
Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells.
Osanai T, Saitoh M, Sasaki S, Tomita H, Matsunaga T, Okumura K
Hypertension (Dallas, Tex. : 1979) 42 ( 5 ) 985 - 90 2003.11
-
[Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
Komatsu T, Yomogida K, Nakamura S, Suzuki O, Horiuchi D, Kameda K, Tomita H, Abe N, Owada S, Oikawa K, Okumura K
Journal of cardiology 42 ( 3 ) 111 - 7 2003.9
-
[Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
Komatsu T, Nakamura S, Suzuki O, Yomogida K, Horiuchi D, Abe N, Kameda K, Owada S, Tomita H, Oikawa K, Okumura K
Journal of cardiology 41 ( 4 ) 191 - 8 2003.4
-
[Long-term efficacy of combination therapy using antiarrhythmic agents and angiotensin converting enzyme inhibitor in patients with paroxysmal and persistent atrial fibrillation: importance of the timing of administration].
Komatsu T, Nakamura S, Suzuki O, Horiuchi D, Owada S, Kameda K, Tomita H, Oikawa K, Abe N, Okumura K
Journal of cardiology 41 ( 2 ) 73 - 80 2003.2
-
Relationship between salt intake, nitric oxide and asymmetric dimethylarginine and its relevance to patients with end-stage renal disease.
Tomohiro Osanai, Naoto Fujiwara, Masayuki Saitoh, Satoko Sasaki, Hirofumi Tomita, Masayuki Nakamura, Hiroshi Osawa, Hideaki Yamabe, Ken Okumura
Blood purification 20 ( 5 ) 466 - 468 2002.5
-
Enhanced activity of variant phospholipase C-delta1 protein (R257H) detected in patients with coronary artery spasm.
Takao Nakano, Tomohiro Osanai, Hirofumi Tomita, Masayuki Sekimata, Yoshimi Homma, Ken Okumura
Circulation 105 ( 17 ) 2024 - 2029 2002.4